Literature DB >> 6085723

Changes of phenotypic characteristics of variants derived from Lewis lung carcinoma during long-term in vitro growth.

A Sacchi, F Mauro, G Zupi.   

Abstract

Two cultured cell clones derived from Lewis lung carcinoma (3LL), which have been shown to differ in their metastatic potential, were studied for their phenotypic stability in vitro. Several growth properties (lag-phase duration, doubling time, saturation density, cell shedding, plating efficiency) have been monitored for more than three years. The ability to induce primary tumors and metastasis, together with the response of cultured cells to adriamycin and bleomycin, have also been evaluated over the same period. The results show that the pattern of metastatic heterogeneity of the two clones is maintained during the serial passages in vitro, although the most actively metastatic clone (C108) displayed a reduced lung colony-forming ability at late passages. Furthermore, both clones exhibited an increasing sensitivity to adriamycin, while no changes were observed in the response to bleomycin. The present data suggest a phenotypic instability of tumor clones adapted to tissue culture conditions and, in particular, that the inherent chemosensitivity of tumor cells may change during long-term culture.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6085723     DOI: 10.1007/bf00052417

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  25 in total

1.  Metastasis results from preexisting variant cells within a malignant tumor.

Authors:  I J Fidler; M L Kripke
Journal:  Science       Date:  1977-08-26       Impact factor: 47.728

2.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

3.  DNA content distribution of in vivo and in vitro lines of Lewis lung carcinoma.

Authors:  G Starace; G Badaracco; C Greco; A Sacchi; G Zupi
Journal:  Eur J Cancer Clin Oncol       Date:  1982-10

4.  Heterogeneity and variability of artificial lung colony-forming ability among clones from mouse fibrosarcoma.

Authors:  N Suzuki; H R Withers; M W Koehler
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

Review 5.  Tumor heterogeneity and the biology of cancer invasion and metastasis.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

Review 6.  Specificity of arrest, survival, and growth of selected metastatic variant cell lines.

Authors:  G L Nicolson; K W Brunson; I J Fidler
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

7.  Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.

Authors:  G H Heppner; D L Dexter; T DeNucci; F R Miller; P Calabresi
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

8.  Establishment of mouse colonic carcinoma cell lines with different metastatic properties.

Authors:  M G Brattain; J Strobel-Stevens; D Fine; M Webb; A M Sarrif
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

9.  Different metastatic potential of in vitro and in vivo lines selected from Lewis lung carcinoma: correlation with response to different bleomycin schedulings.

Authors:  A Sacchi; F Calabresi; C Greco; G Zupi
Journal:  Invasion Metastasis       Date:  1981

10.  In vitro and in vivo selection of two Lewis lung carcinoma cell lines.

Authors:  A Sacchi; A Corsi; M Caputo; G Zupi
Journal:  Tumori       Date:  1979-12-31
View more
  9 in total

1.  Stimulation of tumor cell growth in vitro by a monoclonal antibody to a tumor specific protein (TSP-180) present on the cell surface of 3LL cells.

Authors:  A Sacchi; G Piaggio; M A Rizzo; R Falcioni; S J Kennel
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

Review 2.  Implications of tumor progression on clinical oncology.

Authors:  D R Welch; S P Tomasovic
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

3.  Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants.

Authors:  M G Rizzo; S Soddu; G Tibursi; B Calabretta; A Sacchi
Journal:  Clin Exp Metastasis       Date:  1993-09       Impact factor: 5.150

4.  Metastatic dissemination of 3LL variants after treatment with monoclonal antibody to a tumor-associated antigen.

Authors:  A Sacchi; S Kennel; P G Natali; G Tibursi; C A Ghetti
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

5.  Retinoic acid negatively regulates beta 4 integrin expression and suppresses the malignant phenotype in a Lewis lung carcinoma cell line.

Authors:  C Gaetano; A Melchiori; A Albini; R Benelli; R Falcioni; A Modesti; A Modica; S Scarpa; A Sacchi
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

Review 6.  The Walker 256 Breast Cancer Cell- Induced Bone Pain Model in Rats.

Authors:  Priyank A Shenoy; Andy Kuo; Irina Vetter; Maree T Smith
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

7.  Improved Oxygen Supply to Multicellular Spheroids Using A Gas-permeable Plate and Embedded Hydrogel Beads.

Authors:  Hirotaka Mihara; Mai Kugawa; Kanae Sayo; Fumiya Tao; Marie Shinohara; Masaki Nishikawa; Yasuyuki Sakai; Takeshi Akama; Nobuhiko Kojima
Journal:  Cells       Date:  2019-05-31       Impact factor: 6.600

8.  Characterisation of Walker 256 breast carcinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours.

Authors:  Kate M Lewis; Elizabeth Harford-Wright; Robert Vink; Mounir N Ghabriel
Journal:  Cancer Cell Int       Date:  2013-02-01       Impact factor: 5.722

9.  Hypothalamic food intake regulation in a cancer-cachectic mouse model.

Authors:  Jvalini T Dwarkasing; Miriam van Dijk; Francina J Dijk; Mark V Boekschoten; Joyce Faber; Josep M Argilès; Alessandro Laviano; Michael Müller; Renger F Witkamp; Klaske van Norren
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-11-13       Impact factor: 12.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.